United States · Biotechnology startup
United States · Centessa Pharmaceuticals
Centessa Pharmaceuticals is a pharmaceutical company that focuses on drug development to address significant medical needs.
Funding reportedLast round: Post ipo equity
What company datasets say Centessa Pharmaceuticals raised
Funding, as reported
Reported in all$650Min dollars
Rounds3
Last roundPost ipo equity
Last round dateApr 2024
Investors listed16
Founders and team
From Centessa Pharmaceuticals's own website: 4 on the team.
- Charlene StoudtSenior Vice President, Clinical Development Operations
- Kerstin SchultzSenior Vice President, Global Program Leadership
- Karen AndersonChief People Officer
- Tia BushChief Technology and Quality Officer
On 3 portfolio pages
Investors who name them
Each firm lists Centessa Pharmaceuticals on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biotechnology in United States
Startups like it
- SojournixWaltham · founded 2016Raised
- Receptor Life SciencesSeattle · founded 2017Raised
- Attune PharmaceuticalsNew York · founded 2018Raised
AbbVieNorth Chicago · founded 2012
GrailMenlo Park · founded 2015
EQRxCambridge · founded 2019- Cerevel TherapeuticsBoston · founded 2018
Royalty PharmaNew York · founded 1996
Is this your company?
Add your raise, your deck and your story, and put Centessa Pharmaceuticals in front of investors. Or tell us what we have wrong.